Phase 4 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 22–26 years who live in the local area covered by the screening program
- Women who have not opted out of the cervical screening program and who agree to take part in the study
- Women who attend a screening appointment and agree to have an HPV (human papillomavirus) test as part of routine screening
- Women who agree to be offered the HPV vaccine (Gardasil 9) as part of the study, even if a previous HPV vaccine was received in the past
Who may not be able to join:
- Women with a known history of a severe allergic reaction or hypersensitivity to any ingredient in the Gardasil 9 vaccine, including amorphous aluminium hydroxyphosphate sulphate adjuvant, sodium chloride, L-histidine, polysorbate 80, or sodium borate
- Women with a known history of immune system disorders
- Women who are currently experiencing a serious illness with a high fever (minor illnesses such as a cold, mild upper respiratory infection, or low-grade fever may not be affected — confirm with trial site)
- Women who have received immunoglobulin or any blood-derived products within the 6 months before the first scheduled vaccine dose
- Women who are currently pregnant
- Women who have had a full hysterectomy (complete surgical removal of the uterus)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joakim Dillner, MD, PhD, Karolinska University Hospital Laboratory
Phone: +46703816277
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prevalence of HPV; Prevalence of HPV; Prevalence of HPV
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.